Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Keywords: نجات; Anthracycline; Anthracenedoine; Heart failure; Left ventricular ejection fraction; Salvage;